DAWN logo

DAWN

Profile

Full Name

Day One Biopharmaceuticals, Inc.

Ticker Symbol

DAWN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 27, 2021

Indexes

Not included

Website

http://dayonebio.com

Employees

181

Key Details

Price

$7.27(+8.35%)

Market cap

$736.85M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$131.16M

Annual EPS

-$1.02(+56.96% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.27
DAWN price is $7.27

30-Day Relative Volume

1.64
DAWN 30-day relative volume is 1.64

Price Performance

Price Most recent change

+8.35%
DAWN price was up +8.35% on Apr 9, 2025

Price YTD change

-42.62%
DAWN price is down -42.62% since January 1st

Price 1-year change

-49.44%
DAWN price is down -49.44% year-on-year

Price 3-year change

-34.45%
DAWN price is down -34.45% over the past 3 years

Price Range

Price All-time high

$28.70
DAWN price is currently -74.67% below its historical high of $28.70

Price 3-year low

$5.44
DAWN price is currently +33.64% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$736.85M
DAWN market capitalization is $736.85 million

Market cap 3-year change

+7.32%
DAWN market capitalization is up +7.32% over the past 3 years

Market cap All-time high

$1.94B
DAWN market capitalization is currently -62.06% below its historical high of $1.94 billion

Market cap sector rank

73.79%
DAWN market capitalization is higher than 73.79% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+16%
DAWN shares outstanding is up +16% year-on-year

Shares Outstanding 3-Year Change

+63.71%
DAWN shares outstanding is up +63.71% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.96
DAWN beta is 0.96

200-day SMA

$12.85
DAWN price is currently -43.41% below its 200-day simple moving average

50-day SMA

$9.78
DAWN price is currently -25.68% below its 50-day simple moving average

RSI

36.88
DAWN 14-day relative strength index is 36.88

Volume

1.64
DAWN 30-day relative volume is 1.64

ATR

$0.58
DAWN average true range is $0.58

10-day Historical Volatility

71.46%
DAWN 10-day historical volatility is 71.46%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$131.16M
DAWN annual revenue is $131.16 million

Revenue Analysts estimate

$161.73M
DAWN annual revenue is currently -18.90% lower than the consensus analysts' forecast

Revenue 1-year change

-
DAWN annual revenue 1-year change is unknown

Revenue Sector rank

59.28%
DAWN annual revenue is higher than 59.28% of companies in Healthcare sector

EPS

EPS

-$1.02
DAWN annual earnings per share is -$1.02

EPS Analysts estimate

-$1.42
DAWN annual earnings per share is currently -28.32% lower than the consensus analysts' forecast

EPS 1-year change

+56.96%
DAWN annual earnings per share is up +56.96% year-on-year

EPS Sector rank

56.28%
DAWN annual earnings per share is higher than 56.28% of companies in Healthcare sector

Profit

Gross profit

$125.88M
DAWN annual gross profit is $125.88 million

Gross margin

95.98%
DAWN annual gross profit margin is 95.98%

Operating profit

-$217.27M
DAWN annual operating income is -$217.27 million

Operating margin

-165.65%
DAWN annual operating profit margin is -165.65%

Net income

-$95.50M
DAWN annual net profit is -$95.50 million

Net margin

-72.81%
DAWN annual net profit margin is -72.81%

Expenses

Total expenses

$348.43M
DAWN annual total expenses is $348.43 million

Operating expenses

$343.15M
DAWN annual total operating expenses is $343.15 million

Cost of goods sold

$5.28M
DAWN annual cost of goods sold is $5.28 million

Selling, general & administrative expenses

$115.45M
DAWN annual SGA is $115.45 million

Depreciation and amortization

$2.03M
DAWN annual depreciation & amortization is $2.03 million

Interest expense

-
DAWN annual interest expense value is unknown

Income tax

$7.14M
DAWN annual income tax is $7.14 million

EBIT & EBITDA

EBIT

-$217.27M
DAWN annual earnings before interest & taxes is -$217.27 million

EBITDA

-$215.24M
DAWN annual EBITDA is -$215.24 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$582.79M
DAWN annual total assets is $582.79 million

Non current assets

$20.46M
DAWN annual long term assets is $20.46 million

Current assets

$562.33M
DAWN annual total current assets is $562.33 million

Cash and cash equivalents

$124.97M
DAWN annual cash & cash equivalents is $124.97 million

Accounts receivable

$13.88M
DAWN annual accounts receivable is $13.88 million

Inventory

$3.32M
DAWN annual inventory is $3.32 million

Liabilities

Total liabilities

$80.04M
DAWN annual total liabilities is $80.04 million

Long term liabilities

$6.59M
DAWN annual total long term liabilities is $6.59 million

Current liabilities

$73.45M
DAWN annual total current liabilities is $73.45 million

Accounts payable

$3.26M
DAWN annual accounts payable is $3.26 million

Debt

Total debt

$2.60M
DAWN annual total debt is $2.60 million

Total debt 1-year change

+537.75%
DAWN annual total debt is up +537.75% year-on-year

Long term debt

$2.59M
DAWN annual long term debt is $2.59 million

Short term debt

$10.00K
DAWN annual short term debt is $10.00 thousand

Equity & Capital

Shareholders equity

$502.75M
DAWN annual stockholders equity is $502.75 million

Book value

$502.75M
DAWN annual book value is $502.75 million

Retained earnings

-$554.08M
DAWN annual retained earnings is -$554.08 million

Working capital

$488.88M
DAWN annual working capital is $488.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$78.11M
DAWN annual cash flow from operations is -$78.11 million

Cash from operations 1-year change

+46.81%
DAWN annual cash flow from operations is up +46.81% year-on-year

Cash from investing

-$230.99M
DAWN annual cash flow from investing activities is -$230.99 million

Cash from investing 1-year change

-279.93%
DAWN annual cash flow from investing activities is down -279.93% year-on-year

Cash from financing

$203.29M
DAWN annual cash flow from financing activities is $203.29 million

Cash from financing 1-year change

+23.96%
DAWN annual cash flow from financing activities is up +23.96% year-on-year

CAPEX

CAPEX

$74.27M
DAWN annual capital expenditures is $74.27 million

CAPEX 1-year change

-
DAWN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$152.38M
DAWN annual free cash flow is -$152.38 million

Free cash flow 1-year change

-1.54%
DAWN annual free cash flow is down -1.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

95.98%
DAWN annual gross profit margin is 95.98%

Operating margin

-165.65%
DAWN annual operating profit margin is -165.65%

Net margin

-72.81%
DAWN annual net profit margin is -72.81%

ROA & ROE

ROA

-16.39%
DAWN annual return on assets is -16.39%

ROE

-22.49%
DAWN annual return on equity is -22.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DAWN price to earnings ratio value is unknown

PE ratio Sector rank

-
DAWN price to earnings ratio is unknown

PB Ratio

PB ratio

1.47
DAWN price to book ratio is 1.47

PB ratio Sector rank

54.28%
DAWN price to book ratio is higher than 54.28% of companies in Healthcare sector

PS Ratio

PS ratio

5.62
DAWN price to sales ratio is 5.62

PS ratio Sector rank

69.1%
DAWN price to sales ratio is higher than 69.1% of companies in Healthcare sector

Enterprise value

Enterprise value

$614.48M
DAWN enterprise value is $614.48 million

Enterprise value Sector rank

71.31%
DAWN enterprise value is higher than 71.31% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.85
DAWN EV/EBITDA is -2.85

EV/EBITDA Sector rank

26.13%
DAWN EV/EBITDA is higher than 26.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.66
DAWN annual current ratio is 7.66

Quick ratio

7.61
DAWN annual quick ratio is 7.61

Leverage

Debt to equity

0.00
DAWN annual debt to equity ratio is 0.00

Interest coverage ratio

-
DAWN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
DAWN piotroski f-score value is unknown

Altman Z-Score

4.19
DAWN altman z-score is 4.19

Analyst ratings

Recent major analysts updates

Apr 3, 25 HC Wainwright & Co.
Buy
Mar 25, 25 Goldman Sachs
Buy
Mar 5, 25 JP Morgan
Overweight
Feb 26, 25 Wedbush
Outperform
Feb 26, 25 Needham
Buy
Feb 26, 25 HC Wainwright & Co.
Buy
Feb 10, 25 Goldman Sachs
Buy
Jan 13, 25 Needham
Buy
Jan 7, 25 B of A Securities
Buy
Dec 17, 24 Jones Trading
Buy

Institutional Ownership

Similar stocks

EMBC logo
Embecta (EMBC)
HCSG logo
Healthcare Services (HCSG)
NTLA logo
Intellia Therapeutics (NTLA)
AVXL logo
Anavex Life Sciences (AVXL)
AXGN logo
AxoGen (AXGN)
GYRE logo
Gyre Therapeutics (GYRE)
NRIX logo
Nurix Therapeutics (NRIX)
MYGN logo
Myriad Genetics (MYGN)
PAHC logo
Phibro Animal Health (PAHC)
  • What is the ticker symbol for Day One Biopharmaceuticals?
  • Does Day One Biopharmaceuticals pay dividends?
  • What sector is Day One Biopharmaceuticals in?
  • What industry is Day One Biopharmaceuticals in?
  • What country is Day One Biopharmaceuticals based in?
  • When did Day One Biopharmaceuticals go public?
  • Is Day One Biopharmaceuticals in the S&P 500?
  • Is Day One Biopharmaceuticals in the NASDAQ 100?
  • Is Day One Biopharmaceuticals in the Dow Jones?
  • When was Day One Biopharmaceuticals's last earnings report?
  • When does Day One Biopharmaceuticals report earnings?
  • Should I buy Day One Biopharmaceuticals stock now?

What is the ticker symbol for Day One Biopharmaceuticals?

The ticker symbol for Day One Biopharmaceuticals is NASDAQ:DAWN

Does Day One Biopharmaceuticals pay dividends?

No, Day One Biopharmaceuticals does not pay dividends

What sector is Day One Biopharmaceuticals in?

Day One Biopharmaceuticals is in the Healthcare sector

What industry is Day One Biopharmaceuticals in?

Day One Biopharmaceuticals is in the Biotechnology industry

What country is Day One Biopharmaceuticals based in?

Day One Biopharmaceuticals is headquartered in United States

When did Day One Biopharmaceuticals go public?

Day One Biopharmaceuticals's initial public offering (IPO) was on May 27, 2021

Is Day One Biopharmaceuticals in the S&P 500?

No, Day One Biopharmaceuticals is not included in the S&P 500 index

Is Day One Biopharmaceuticals in the NASDAQ 100?

No, Day One Biopharmaceuticals is not included in the NASDAQ 100 index

Is Day One Biopharmaceuticals in the Dow Jones?

No, Day One Biopharmaceuticals is not included in the Dow Jones index

When was Day One Biopharmaceuticals's last earnings report?

Day One Biopharmaceuticals's most recent earnings report was on Feb 25, 2025

When does Day One Biopharmaceuticals report earnings?

The next expected earnings date for Day One Biopharmaceuticals is May 6, 2025

Should I buy Day One Biopharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page